Isolated low HDL cholesterol: An insulin-resistant state only in the presence of fasting hypertriglyceridemia

Diabetes

Volumn 48, Issue 5, 1999, Pages 1088-1092

  Tai, E Shyong ^a   Emmanuel, Shanta C ^b   Chew, Suok Kai ^b   Tan, Bee Yian ^b   Tan, Chee Eng ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b MINISTRY OF HEALTH   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOCHOLESTEROLEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; CHOLESTEROL, HDL; DIASTOLE; FASTING; HUMANS; HYPERTRIGLYCERIDEMIA; INDIA; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY;

EID: 0032940252     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.5.1088     Document Type: Article

References (25)

1. Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA; High-density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 131:32-47, 1990
2. Goldbourt U, Holtzman E, Neufeld HN: Total and high-density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect BMJ 290:1239-1243, 1985
3. Burchfiel CM, Laws A, Benfante R, Goldberg RJ, Hwang LJ, Chiu D, Rodriguez BL, Curb JD, Sharp DS: Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation 92:1430-1436, 1995
4. Goldbourt U, Yaari S, Medalie JH: Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21-year follow-up of 8,000 men. Arterioscler Thromb Vasc Biol 17:107-113, 1997
5. Rubins HB, Schectman G, Wilt TJ, Iwane MK: Distribution of lipid phenotypes in community-living men with coronary heart disease: high prevalence of isolated low levels of high-density lipoprotein cholesterol [see comments]. Arch Intern Med 152:2412-2416, 1992
6. Miller M, Kwiterovich PO Jr: Isolated low HDL cholesterol as an important risk factor for coronary heart disease. Eur Heart J 11 (Suppl. H):9-14, 1990
7. Castelli WP: Lipids, risk factors, and ischaemic heart disease. Atherosclerosis 124 (Suppl.): 1-9, 1996
8. Assmann G, Cullen P, Schulte H: The Munster Heart Study (PROCAM): results of follow-up at 8 years. Eur Heart J 19 (Suppl. A):A2-11, 1998
9. Lemarche B, Despres J-P, Moorjani S, Cantin B, Dagenais GR, Lupien P-J: Prevalence of dyslipidemic phenotypes in ishaemic heart disease: prospective results from the Quebec Cardiovascular Study. Am J Cardiol 75:1189-1195, 1995
10. Miller M, Seidler A, Kwiterovich PO, Pearson TA: Long-term predictors of subsequent cardiovascular events with coronary artery disease and "desirable" levels of plasma total cholesterol. Circulation 86:1166-1170, 1992
11. Assmann G, Funke H: HDL metabolism and atherosclerosis. J Cardiovasc Pharmacol 16 (Suppl. 9):15-20, 1990
12. Tan CE, Emmanuel SC, Tan BY, Jacob E: Prevalence of diabetes mellitus and ethnic differences in cardiovascular risk factors: the 1992 Singapore National Health Survey. Diabetes Care 22:241-247, 1999
13. Campos H, Bailey SM, Gussak LS, Siles X, Orvados M, Schaefer EJ: Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arterioscler Thromb Vasc Biol 11:1077-1088, 1991
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
15. Castelli WP: Epidemiology of triglycerides: a view from Framingham [see comments]. Am J Cardiol 70:3H-9H, 1992
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993
17. World Health Organization: WHO Expert Committee on Diabetes Mellitus: Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
18. Austin MA: Plasma triglyceride and coronary heart disease. Arterioscler Thromb Vasc Biol 11:2-14, 1991
19. Karhapaa P, Malkki M, Laakso M: Isolated low HDL cholesterol: an insulin-resistant state. Diabetes 43:411-417, 1994
20. Lemarche B, Despres J-P, Pouliot M-C, Prud'homme D, Moorjani S, Lupien PJ, Nadeau A, Tremblay A, Bouchard C: Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb Vasc Biol 13:33-40, 1992
21. Austin M, King M, Vranizan K, Krauss R: Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease. Circulation 82:195-505, 1990
22. Campos H, Blijlevens E, McNamara JR: LDL particle size distribution: results from the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 12:1410-1419, 1992
23. Harris-Hooker S, Sanford GL: Lipids, lipoproteins, and coronary heart disease in minority populations. Atherosclerosis 108 (Suppl.):83-104, 1994
24. Le NA, Ginsberg HN: Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high-density lipoprotein cholesterol Metabolism 37:614-617, 1988
25. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stem MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722, 1992